Abstract 2714: Development of a novel Ikaros/Aiolos transcriptional signature and correlation with patient response in multiple myeloma patients treated with CELMoDs.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148650679
Cites:
Cited by:
Related to:
